Actiza Pharmaceutical Private Limited

Levetiracetam API Powder is used alone or together with other medicines to help control certain types of seizures (eg, partial seizures, myoclonic seizures, or tonic-clonic seizures) in the treatment of epilepsy. This medicine cannot cure epilepsy and will only work to control seizures for as long as you continue to use it.

Tranexamic Acid API Powder is a high-quality antifibrinolytic agent widely used in the pharmaceutical industry for the prevention and treatment of excessive bleeding. As a synthetic derivative of lysine, it works by inhibiting plasminogen activation, helping to stabilize blood clots and reduce bleeding. This pharmaceutical-grade active ingredient is essential in formulations for surgical procedures, trauma care, and various medical conditions related to abnormal bleeding.

2-(2-Methoxy phenoxy) Ethyl Amine hydrochloride (CAS: 64464-07-9) is primarily used as an intermediate in the pharmaceutical industry, notably in the synthesis of Carvedilol, a widely used medication for heart conditions like hypertension and heart failure.

The citrate salt form of clomiphene, a triphenylethylene nonsteroidal ovulatory stimulant evaluated for antineoplastic activity against breast cancer. Clomiphene has both estrogenic and anti-estrogenic activities that compete with estrogen for binding at estrogen receptor sites in target tissues.

Deferasirox is an oral iron-chelating agent used to reduce chronic iron overload in patients receiving frequent blood transfusions (transfusional hemosiderosis), as well as in non-transfusion-dependent thalassemia.

It binds excess iron in the blood and promotes its excretion through the feces.